Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP6 The Many Names of Fenbendazole: Understanding Its Interchangeable Terminology
Fenben® Voices
4 minutes
1 year ago
S1EP6 The Many Names of Fenbendazole: Understanding Its Interchangeable Terminology
Got Questions? Send us a message!Podcast Episode Description:Dive into "The Many Names of Fenbendazole: Understanding Its Interchangeable Terminology" on "Fenben Voices," where we unravel the mystery behind the various names of a widely recognized deworming agent turned potential cancer fighter. This episode explores:The significance and origins of names like Fenbendazole, Fenben, Panacur, and SafeGuard.Insights from research studies on the interchangeable use of these terms.The impact of ter...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
